Pauwels Eric

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
30
Insider Sells Sum
$2.89M

Insider Activity of Pauwels Eric

According to the SEC Form 4 filings, Pauwels Eric, being in a position of

  1. CHIEF BUSINESS OFFICER at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 18687 shares for $965,013,
    over all time since 2020-11-03, has bought 0 shares, and sold 55557 shares for $2.89M.

The largest sale of all time was on 2023-05-17 and amounted to 8048 shares of PTC Therapeutics, Inc. for $470,822.

Biography of Pauwels Eric

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $965,0137100

Comparison of Insiders on Amount of Buys and Sells

2025-03-17SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
6,762
0.0085%
$56.80$384,067-2.34%
2025-03-14SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
4,458
0.0057%
$55.19$246,037
2025-02-20SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
1,567
0.002%
$50.12$78,544+4.72%
2025-02-19SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
1,378
0.0018%
$50.10$69,032+4.13%
2025-01-08SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,136
0.0028%
$44.50$95,052+11.01%
2025-01-07SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
1,599
0.0021%
$45.34$72,499+12.06%
2024-04-17SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
787
0.001%
$25.14$19,781+49.68%
2024-01-30SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
366
0.0005%
$27.25$9,974+29.48%
2024-01-09SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
2,065
0.0028%
$29.01$59,916+17%
2024-01-08SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
1,569
0.002%
$28.64$44,937+11.97%
2023-05-22SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
2,013
0.0027%
$59.01$118,791-51.73%
2023-05-19SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
6,403
0.0088%
$58.96$377,491-51.25%
2023-05-18SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
788
0.0011%
$58.71$46,267-50.99%
2023-05-17SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
8,048
0.011%
$58.50$470,822-51.06%
2023-04-18SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
732
0.001%
$52.04$38,096-45.6%
2023-01-31SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
375
0.0005%
$45.63$17,111-12.4%
2023-01-24SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
359
0.0005%
$47.45$17,035-14.68%
2023-01-11SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
571
0.0008%
$44.36$25,329-10.8%
2023-01-10SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
663
0.0009%
$42.93$28,465-7.73%
2023-01-09SalePTC Therapeutics, Inc.
PTCT
CHIEF BUSINESS OFFICER
858
0.0012%
$41.66$35,741-1.51%
Total: 30
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.